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Abstract
Aortic stiffness is an independent predictor factor for cardiovascular risk. Different methods for determining pulse
wave velocity (PWV) are used, among which the most common are mechanical methods such as SphygmoCor or
Complior, which require specific devices and are limited by technical difficulty in obtaining measurements. Doppler
guided by 2D ultrasound is a good alternative to these methods. We studied 40 patients (29 male, aged 21 to 82
years) comparing the Complior method with Doppler. Agreement of both devices was high (R = 0.91, 0.84-0.95,
95% CI). The reproducibility analysis revealed no intra-nor interobserver differences. Based on these results, we
conclude that Doppler ultrasound is a reliable and reproducible alternative to other established methods for the
measurement of aortic PWV.
Introduction
Large arteries are not simple tube conduction structures.
They moderate systolic pressure increases and maintain
sufficient diastolic level to guarantee myocardial perfu-
sion. With the identification of new diseases and risk
factors, it has been seen that these arteries lose their
natural elasticity leading to high systolic and low diasto-
lic blood pressure levels, which determine high pulse
pressure.
Based on these premises, arterial stiffness is now con-
sidered an increasingly important biomarker in the eva-
luation of cardiovascular risk and the detection of
incipient vascular disease. Several studies have shown
that this parameter is an independent predictor of cardi-
ovascular mortality in the elderly, hypertensive,
diabetics, and patients with chronic renal failure as well
as in the general population [1-4]. The guidelines of the
European Societies of Hypertension and Cardiology
(2007-2009) have postulated arterial stiffness assessment,
measurement of the carotid plaque and ankle/brachial
index as markers of vascular status. Any alteration of
these measurements may define a state of vasculopathy
that significantly increases the evaluation of risk [5].
Among the different methods of evaluating arterial
stiffness, the most widely used in the literature is aortic
pulse wave (PWV), specifically in the area running from
the aortic arch or common carotid artery to the com-
mon femoral artery. Typically, the pulse wave is
detected by pressure transducers or arterial tonometry.
The measurement of carotid-femoral PWV (Figure 1)
is made by dividing the distance (from the carotid point
to the femoral point) by the so-called transit time (the
time of travel of the foot of the wave over the distance).
Hence, PWV = D (meters)/Dt (seconds) [6,7].
Whereas the distance is a fixed parameter, the transit
time has a certain variability, depending on factors such
as cardiac conduction and rhythm. Given this situation,
most methods take the average of several measurements.
T h e s em e t h o d sa r eh i g h l yr e l i a b l eb u th a v et h ed i s a d -
vantages of requiring specific devices and software and
of sometimes being impossible to perform accurately
due to the difficulty in recording good pulse waves.
F u r t h e r m o r e ,t h et i m er e q u i r e df o rt h ee x p l o r a t i o ni s
not negligible.
These disadvantages are overcome if we take the caro-
tid-femoral PWV measurement by ultrasound, making
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flow wave of spectral Doppler. In fact, this method has
been used in population-based studies such as the ABC
study [8-13]. On this basis, we designed a comparative
study to assess whether PWV measured by mechanical
pressure and PWV estimated by ultrasound are similar,
and reliable in the measurement of arterial stiffness.
Material and methods
The subjects studied were patients from the Cardiovas-
cular Risk and Hypertension Unit of the Dr. Josep
Trueta University Hospital. Inclusion criteria were
patients with essential hypertension, diabetes mellitus or
chronic kidney disease and indications to testing were
the evaluation of specific cardiovascular risk. Exclusion
criteria were atrial fibrillation, severe cardiac valve dis-
ease and the presence of a prosthetic aorta. Both
PWVc-f by the Complior
® method and Doppler ultra-
sound measurements were performed on all patients by
two investigators. Other clinical variables such as blood
pressure and heart rate were also recorded. The study
was approved by the Hospital Dr. Josep Trueta Ethics
Committee.
PWV measured by mechanotransducers
The Complior
® System (Artech Medical, Pantin, France)
was used as the method of reference to determine
PWVc-f, which was automatically calculated as the aver-
age of 8-10 transit times and the distance, measured
from the sternal notch to the femoral artery at the
groin. The test was performed in supine position, pla-
cing sensors at the carotid and femoral pulses (at the
area of maximum heart rate by palpation). The result
was the average of two or three speed measurements.
PWV measured by Doppler
Although it is not possible to analyze the carotid and
femoral waves simultaneously, they can be normalized
separately with the electrocardiogram (ECG) (gatting).
We used a pulsed Doppler ultrasound with a Linear
Array (6.6 MHZ) probe, synchronized with ECG and a
two-second minimum sliding window (MyLab25, Esaote,
Florence, Italy). The examination began with the patient
in a supine position after locating the carotid artery
with B-mode at the supraclavicular level (1-2 cm of the
bifurcation). We then identified the wave Doppler flow
simultaneously with ECG. The process was repeated on
the common femoral artery in the groin. We performed
three recordings of the carotid artery and three record-
ings of the femoral artery in the groin. Each recording
involved two or three cardiac cycles. To find the transit
time (TT), we measured the time from the R wave of
QRS to the foot of the waveform using digital calipers
(Figure 2). Six heart rate measurements were taken and
the average was calculated. To determine the velocity,
we used the same distance as the Complior
® system.
To check reproducibility two blinded observers sepa-
rately measured the PWV using the Doppler images of
10 consecutive patients. One observer later repeated the
measurements twice at different times.
Sample size
The available sample size (n = 40) provided power >90%
at 1% significance level in order to contrast the null
hypothesis that the ICC equals 0.7 and the alternative
hypothesis that the ICC equals 0.9 (two-sided). Study-
Size 2.0 Trial software was used for sample size
calculations.
Statistical analysis
Continuous variables were described with mean and
standard deviation and percentages were used to
describe qualitative variables. Agreement between PWV
measured by Doppler and Complior as well as the intra-
and inteobserver agreement of the new technique was
calculated based on intraclass correlation coefficient
(ICC). Bland-Altmann plots were used to determine pre-
cision and bias between methods. The analysis is based
on the examination of two graphs: first, the identity plot
(a scatterplot of the two measurements along with the
line y = x); second, the plot of the difference between
methods against the gold standard (Complior).
Results
A heterogeneous group of 47 patients aged from 21 to
82 years were studied in 2009 and 2010. Seven patients
Figure 1 Pulse wave velocity determination. Transit time is
estimated by the foot-to-foot method. The foot of the wave is
defined at the end of diastole, when the steep rise of the waveform
begins. The transit time is the time of travel of the foot of the wave
over a known distance.
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failure to perform the Complior technique (inability to
find a correct carotid pulse wave) and one due to the
presence of aortic prostheses.
The sample characteristics are detailed in Table 1.
PWV Complior (9.81 ± 2.76) ranged from 4.13 m/s to
19.9 m/s, similar to the PWV Doppler (9.95 ± 3.13)
from 3.96 m/s to 20.2 m/s. The mean difference
between the two measures was virtually the same 0.13
(0.19). The two methods showed very good agreement
(R = 0.91, 0.84-0.95; CI 95%). The analysis of reproduci-
bility also showed very good agreement (Table 2)
T h ei d e n t i t yp l o ti nF i g u r e3s h o w e db a s i ca g r e e m e n t
between the two methods since the scatterplot lined up
c l o s e l yt ot h el i n ey=x .M o r e o v e r ,t h eB l a n d - A l t m a n
plot (Figure 4) indicated that the 95% limits of agree-
ment ranged from -2 to +2. Hence, the two methods
provided similar measures as the level of disagreement
did not include clinically important discrepancies.
Discussion
Age, atherosclerosis and the presence of certain diseases
are known to decrease arterial elasticity. As can be seen
in Table 3, there are many methods to estimate arterial
stiffness, which has now taken on great importance in
assessing cardiovascular risk. Non-invasive methods are
based on local, regional or systemic measures. Direct
measurement of local stiffness is usually made by echo-
tracking systems, which measure in situ the differences
of arterial diameter over the wave flow.
The most commonly used regional method is aortic
pulse wave velocity, which requires two variables: the dis-
tance between two points in the artery and the time taken
by the pulse to cover that distance. Carotid-femoral PWV
is a simple, non-invasive, robust and reproducible method
that is regarded as the gold standard for measuring arterial
Figure 2 Time measurement in femoral arthery gatting with ECG in two heart rates.
Table 1 Subject characteristics (n = 40)
Variable Mean or number of patients
(s.d. or %)
Gender (F/M) 11 (27.5%)/29(72.5%)
Age (years) 59 (15.8)
Diabetes Mellitus 11 (27.5%)
Cronic kidney failiure (FG < 60
ml/min)
21 (52.5%)
Sistolic BP (mmHg) 131 (16.4)
Diastolic BP (mmHg) 74 (10.5)
Path length (cm) 54.3 (4.5)
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an independent predictor of cardiovascular events.
The Complior System
®, which uses two mechano-
transducers applied to the skin and measures real-time
pulse waves at carotid and femoral points, is used in
most of these studies. Another widely used system is
SphygmoCor
®, which uses an applanation tonometer
[6-16]. This device can also calculate the central pres-
sure and augmentation index.
Complior records both waves simultaneously, whereas
SphygmoCor records consecutively using ECG. In this
case, changes in heart rate between two recordings may
determine a variation in transit time.
These mechanical methods have the disadvantages
that there is a prolonged learning period in order to
become an experienced observer and that the devices
used lack versatility. Furthermore, the technical difficulty
in obtaining measurements and anatomical limitations
of some patients make it necessary to find faster and
more versatile methods for measuring PWV [17]. The
measurement of stiffness by ultrasound has the advan-
tages of being significantly quicker and of not requiring
a specific device.
Several studies, the largest of which was undertaken by
Sutton-Tyrrell et al. and included 2488 patients, have used
Doppler ultrasound to measure aortic PWV. Table 4 sets
out the main PWV studies together with the methods
employed [18]. However, few studies have compared a
mechanical method with the use of Doppler [19].
This study demonstrates that Doppler ultrasound
c a nb eu s e dt om e a s u r ea o r t i cP W Vi nar e l i a b l ea n d
reproducible way, giving similar results to Complior
®,
which we took as a gold-standard. In addition, B-mode
ultrasound provides an anatomical image that can
increase the precision of measurements (for example,
using the carotid or femoral bifurcation as a refer-
ence). This method has the further advantages of
shorter performance time, short learning curve and
the absence of anatomical limitations, which are espe-
cially pronounced in the carotid artery. The versatility
of ultrasound also permits us to explore simulta-
neously other pathologies such as plaques or blockages
in the carotid and femoral territories as well as to
assess intima-media thickness.
Table 2 Agreement between methods and intraobserver
and interobsever reproductibility
ICC* Mean
differences
Standard error of
mean difference
Between
methods
0.91 (0.84-0.95) 0.13 0.19
Intraobserver 0.98 (0.92-0.99) 0.32 0.29
Interobserver 0.97 (0.89-0.99) -0.18 0.38
Figure 3 Identity plot. Comparison of Doppler and Complior
PWV measurement methods.
Figure 4 Bland and Altman plot of Complior vs. Doppler PWV
with mechanical method as reference. The intervals of two
standard deviations are considered as the concordance limits
between the two measurements, accounting for 95% of the
observed differences.
Table 3 Devices and methods used to determine arterial
stiffness
Non-invasive Regional stiffness: Mechanotransducer
Pulse wave velocity Tonometer
Echotracking
Doppler
Local stiffness Echotracking
Magnetic resonance
Systemic stiffness Waveform shape analysis
Invasive Aortic angiography
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The aim of this study was to consider the use of
Doppler as an alternative to a more established method
(Complior
®) of measuring pulse wave velocity and to
highlight certain advantages that Doppler has over this
reference technique. Although the number of patients
studied in this first study to specifically compare these
two devices is limited, the findings are sufficiently
powerful to demonstrate a high correlation between the
two systems and so to justify the use of Doppler ultra-
sound both in clinical practice and clinical studies to
assess arterial stiffness. However, automated methods
should be developed for calculating transit time to
reduce the variability from the use of manual calipers.
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